Braund, Taylor A. http://orcid.org/0000-0001-8408-9070
Tillman, Gabriel
Palmer, Donna M.
Gordon, Evian
Rush, A. John
Harris, Anthony W. F. http://orcid.org/0000-0002-8617-4962
Article History
Received: 4 January 2021
Revised: 14 July 2021
Accepted: 23 July 2021
First Online: 4 August 2021
Competing interests
: TAB, DMP, and EG report salaries from Total Brain outside the submitted work. EG is the CMO at Total Brain and holds significant equity and stock options in the company. AWFH reports personal fees from Janssen Australia, Lundbeck Australia, Servier Australia, and Takeda Pharmaceutical Company outside the submitted work. AJR has received consulting fees from Akili, Brain Resource Inc., Compass Inc., Curbstone Consultant LLC, Emmes Corp., Holmusk, Inc., Liva-Nova, Johnson & Johnson (Janssen), Sunovion, Takeda USA, and Taj Medical; speaking fees from LivaNova; and royalties from Guilford Press and the University of Texas Southwestern Medical Center, Dallas, TX (for the Inventory of Depressive Symptoms and its derivatives). He is also named co-inventor on two patents: US Patent No. 7,795,033: Methods to predict the outcome of treatment with antidepressant medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S, Wilson AS and US Patent No. 7,906,283: Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication, Inventors: McMahon FJ, Laje G, Manji H, Rush AJ, Paddock S. GT has no conflicts of interest to report.